Please wait while we open this resource.
K
Guidelines & protocols
METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): ASSESSMENT AND MANAGEMENT
National Institute for Health and Care Excellence (NICE)
PDF201620 pages106 KB
The guideline outlines the responsibilities of healthcare professionals in applying the recommendations, which are based on a thorough review of available evidence. It covers monitoring for advanced liver fibrosis, the relationship between MASLD and other health conditions, and lifestyle interventions. The document also addresses pharmacological treatments and updates terminology related to liver disease. It aims to support healthcare providers in delivering effective care for patients with MASLD.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
UGANDA GUIDELINES FOR PREVENTION, TESTING, CARE AND TREATMENT OF HEPATITIS B AND C VIRUS INFECTION
Same clinical topic · Hepatology
EASL Clinical Practice Guidelines on Vascular Diseases of the Liver
Same clinical topic · Hepatology
GUIDELINES FOR THE PREVENTION, DIAGNOSIS, CARE AND TREATMENT FOR PEOPLE WITH CHRONIC HEPATITIS B INFECTION
Same clinical topic · Hepatology
Hepatitis E Virus, Second Edition (Springer, 2023)
Same specialty · Hepatology
metabolic liver disease, PBC and PSC charles
Same specialty · Hepatology
AUTOIMMUNE HEPATITIS
Same specialty · Hepatology
MOLECULAR MECHANISMS AND PATHOGENESIS OF MASH
Same specialty · Hepatology
CIRRHOSIS, PORTAL HYPERTENSION AND HEPATOCELLULAR CARCINOMA: A STAGE-BASED APPROACH
Same specialty · Hepatology
NEW APPROACHES TO CHRONIC HEPATITIS B
Same specialty · Hepatology